Literature DB >> 24904879

Serum glycated albumin as a new glycemic marker in pediatric diabetes.

Ji Woo Lee1, Hyung Jin Kim1, Young Se Kwon1, Yong Hoon Jun1, Soon Ki Kim1, Jong Weon Choi2, Ji Eun Lee1.   

Abstract

PURPOSE: Serum glycated albumin (GA) has been recently used as another glycemic marker that reflects shorter term glycemic control than glycated hemoglobin (HbA1c). Insulin secretory function and glycemic fluctuation might be correlated with the ratio of GA to HbA1c (GA/HbA1c) in diabetic adult patients. This study investigated the association of GA and GA/HbA1c ratio with the levels of fasting C-peptide, fasting plasma glucose in type 1 and type 2 pediatric diabetes.
METHODS: Total 50 cases from 42 patients were included. The subjects were classified into type 1 diabetes mellitus (T1DM) (n=30) and type 2 diabetes mellitus (T2DM) (n=20) group. The associations among HbA1c, GA, and GA/HbA1c ratio were examined. The relationship between the three glycemic indices and fasting glucose, fasting C-peptide were analyzed.
RESULTS: Mean values of GA, the GA/HbA1c ratio were significantly higher in T1DM than T2DM. GA (r=0.532, P=0.001), HbA1c (r=0.519, P=0.002) and the GA/HbA1c ratio (r=0.409, P=0.016) were correlated with the fasting plasma glucose. Fasting C-peptide level arranged 4.22±3.22 ng/mL in T2DM, which was significantly above the values in T1DM (0.26±0.49 ng/mL). There were no significant correlation between HbA1c and fasting C-peptide level. However, GA and the GA/HbA1c ratio exhibited inverse correlations with fasting C-peptide level (r=-0.214, P=0.002; r=-0.516, P<0.001).
CONCLUSION: GA seems to more accurately reflects fasting plasma glucose level than HbA1c. GA, GA/HbA1c ratio appear to reflect insulin secretory function.

Entities:  

Keywords:  Child; Diabetes mellitus; Glycosylated hemoglobin A; Glycosylated serum albumin

Year:  2013        PMID: 24904879      PMCID: PMC4027086          DOI: 10.6065/apem.2013.18.4.208

Source DB:  PubMed          Journal:  Ann Pediatr Endocrinol Metab        ISSN: 2287-1012


  21 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

2.  Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).

Authors:  Tomoko Suwa; Akio Ohta; Tomoya Matsui; Rieko Koganei; Hiroyuki Kato; Takehiro Kawata; Yukiyoshi Sada; Satoshi Ishii; Akihiko Kondo; Kaori Murakami; Takuyuki Katabami; Yasushi Tanaka
Journal:  Endocr J       Date:  2009-11-19       Impact factor: 2.349

3.  Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.

Authors:  Y Tahara; K Shima
Journal:  Diabetes Care       Date:  1995-04       Impact factor: 19.112

4.  The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function.

Authors:  Daham Kim; Kwang J Kim; Ji H Huh; Byung-Wan Lee; Eun S Kang; Bong S Cha; Hyun C Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

5.  Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

Authors:  Kazutomi Yoshiuchi; Munehide Matsuhisa; Naoto Katakami; Yoshihisa Nakatani; Kenya Sakamoto; Takaaki Matsuoka; Yutaka Umayahara; Keisuke Kosugi; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  Endocr J       Date:  2008-04-30       Impact factor: 2.349

6.  Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus.

Authors:  Masumi Ai; Seiko Otokozawa; Ernst J Schaefer; Bela F Asztalos; Katsuyuki Nakajima; Peter Shrader; Sekar Kathiresan; James B Meigs; Gordon Williams; David M Nathan
Journal:  Clin Chim Acta       Date:  2009-05-22       Impact factor: 3.786

7.  Is serum fructosamine assay specific for determination of glycated serum protein?

Authors:  E D Schleicher; R Mayer; E M Wagner; K D Gerbitz
Journal:  Clin Chem       Date:  1988-02       Impact factor: 8.327

8.  The prediabetic period: review of clinical aspects.

Authors:  Sang Youl Rhee; Jeong-Taek Woo
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

9.  The association of unintentional changes in weight, body composition, and homeostasis model assessment index with glycemic progression in non-diabetic healthy subjects.

Authors:  Eun-Jung Rhee; Ji-Hun Choi; Seung-Hyun Yoo; Ji-Cheol Bae; Won-Jun Kim; Eun-Suk Choi; Se Eun Park; Cheol-Young Park; Seok Won Park; Ki-Won Oh; Sung-Woo Park; Sun-Woo Kim; Won-Young Lee
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

10.  A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women.

Authors:  Kunihiko Hashimoto; Tomoaki Osugi; Sanai Noguchi; Yasuhiko Morimoto; Kenshi Wasada; Shiro Imai; Masako Waguri; Rieko Toyoda; Tomio Fujita; Soji Kasayama; Masafumi Koga
Journal:  Diabetes Care       Date:  2009-12-23       Impact factor: 19.112

View more
  5 in total

1.  Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.

Authors:  Xiwei Zheng; Maria Podariu; Ryan Matsuda; David S Hage
Journal:  Anal Bioanal Chem       Date:  2015-10-13       Impact factor: 4.142

Review 2.  Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.

Authors:  Ji-Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

3.  The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Authors:  Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin
Journal:  Pediatr Diabetes       Date:  2021-12-26       Impact factor: 4.866

4.  Multi-Biomarkers for Early Detection of Type 2 Diabetes, Including 10- and 12-(Z,E)-Hydroxyoctadecadienoic Acids, Insulin, Leptin, and Adiponectin.

Authors:  Aya Umeno; Kohzoh Yoshino; Yoshiko Hashimoto; Mototada Shichiri; Masatoshi Kataoka; Yasukazu Yoshida
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 5.  MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.

Authors:  Suniti Vaishya; Rucha D Sarwade; Vasudevan Seshadri
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.